Evercore ISI Begins Coverage on Dyne Therapeutics (NASDAQ:DYN)
Stock analysts at Evercore ISI started coverage on shares of Dyne Therapeutics (NASDAQ:DYN – Get Free Report) in a research note issued on Thursday, MarketBeat Ratings reports. The firm set an “outperform” rating and a $46.00 price target on the stock. Evercore ISI’s price target would suggest a potential upside of 289.17% from the company’s […]
Stock analysts at Evercore ISI started coverage on shares of Dyne Therapeutics (NASDAQ:DYN – Get Free Report) in a research note issued on Thursday, MarketBeat Ratings reports. The firm set an “outperform” rating and a $46.00 price target on the stock. Evercore ISI’s price target would suggest a potential upside of 289.17% from the company’s […]
